Ceretas Company Description

Ceretas Limited, a medical technology company that develops portable and non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions in Australia.

The company’s technology operates through two primary mechanisms, including neuromodulation, which uses low-intensity focused ultrasound to stimulate neural circuits; and BBBO, which temporarily and reversibly opens the blood-brain barrier using ultrasound combined with circulating microbubbles that facilitates brain's natural clearance of amyloid-beta and tau and helps delivery of co-administered drugs to targeted brain regions.

Ceretas Limited was incorporated in 2024 and is based in Brisbane, Australia.

Ceretas Limited

Country	Australia
Founded	2024
Industry	Medical Care Facilities
Sector	Healthcare
CEO	Rachel de las Heras

Contact Details

Address: 348 Edward Street Brisbane, QLD 4000 Australia
Phone	61 7 3543 4424
Website	ceretas.com.au

Stock Details

Ticker Symbol	CTS
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU0000475766
SIC Code	3845

Key Executives

Name	Position
Dr. Rachel de las Heras	Co-Founder, Chief Executive Officer, MD and Executive Director
Sam Wetzler	Co-Founder and Non-Executive Director
Al Rey Lunar CPA	Chief Financial Officer
Vesa Peltonen	Chief Technology Officer
Dr. Anthony James Keating	Executive Director
Nicki Farley B.A., L.L.B.	Company Secretary